vTv Therapeutics Revenue and Competitors

High Point, NC USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • vTv Therapeutics's estimated annual revenue is currently $11.5M per year.(i)
  • vTv Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • vTv Therapeutics has 57 Employees.(i)
  • vTv Therapeutics grew their employee count by -7% last year.

vTv Therapeutics's People

NameTitleEmail/Phone
1
Chief Accounting OfficerReveal Email/Phone
2
Sr VP, Chemistry, Pharmaceutical Development, and QualityReveal Email/Phone
3
VP Clinical OperationsReveal Email/Phone
4
VP, Business DevelopmentReveal Email/Phone
5
VP, CMCReveal Email/Phone
6
SVP Biometrics and Regulatory AffairsReveal Email/Phone
7
SVP Clinical DevelopmentReveal Email/Phone
8
EVP, Corporate DevelopmentReveal Email/Phone
9
EVP and Chief Financial OfficerReveal Email/Phone
10
Chief Quality OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.8M294%N/AN/A
#2
$3.2M160%N/AN/A
#3
$83.2M4147%N/AN/A
#4
$31M15456%N/AN/A
#5
$66.6M2650%$35MN/A
#6
$10.9M546%N/AN/A
#7
$6.8M34-6%N/AN/A
#8
$165.7M21614%$250.7MN/A
#9
$26.5M132-11%$637.8KN/A
#10
$49.4M2466%N/AN/A
Add Company

What Is vTv Therapeutics?

vTv Therapeutics is a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. Our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. We have a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, diabetes and metabolic disorders, inflammation and cancer.

keywords:N/A

N/A

Total Funding

57

Number of Employees

$11.5M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

vTv Therapeutics News

2022-04-17 - Does vTv Therapeutics Inc (VTVT) Have What it Takes to be in Your Portfolio Tuesday?

vTv Therapeutics Inc also achieved a score of 57 in the Biotechnology industry, putting it above 57 percent of Biotechnology stocks.

2022-03-30 - vTv Therapeutics reports $17.6 million loss in 2021, names ...

High Point clinical stage pharmaceutical company vTv Therapeutics Inc. (Nasdaq: VTVT) reported a net loss of $17.6 million in 2021 when it...

2022-03-22 - vTv Therapeutics Announces 2021 fourth Quarter and Full ...

vTv Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M576%N/A
#2
$13.3M59N/AN/A
#3
$13.2M605%N/A
#4
$3.5M607%N/A
#5
$8.2M6145%N/A